InvestorsHub Logo
Followers 496
Posts 62722
Boards Moderated 0
Alias Born 08/28/2010

Re: None

Tuesday, 10/08/2019 9:17:25 AM

Tuesday, October 08, 2019 9:17:25 AM

Post# of 640523
$GTBP put on watch! ~ GT Biopharma had huge news last week updating HIV TriKE™ >>

GT Biopharma Announces HIV TriKE™ Data Demonstrating NK Cell Killing of Patient HIV Infected Cells

https://finance.yahoo.com/news/gt-biopharma-announces-hiv-trike-140500239.html

To Note: "Research findings from Dr. Schacker's and Dr. Miller's laboratories show enhanced NK cell cytokine production and killing of infected targets expressing HIV-Env when incubated with the HIV-TriKE™. Peripheral blood mononuclear cells (T-cells, B-cells, NK cells and monocytes) from healthy donors incubated with the HIV-TriKE™ showed marked increases in immune cell activation in NK cell, CD4 T-cell and CD8 T-cell population subsets. The HIV-TriKE™ also induced NK cell proliferation, and demonstrated the ability in vitro to reactivate and kill HIV-infected T-cells.

These findings indicate a potential role for the HIV-TriKE™ in the reactivation and elimination of the latently infected HIV reservoir cells by harnessing the NK cell's ability to mediate the antibody-directed cellular cytotoxicity (ADCC)."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.